Transenterix Inc. Daily Stock Analysis

Daily Stock Analysis, TRXC, Transenterix Inc, priceseries

Transenterix Inc. Daily Stock Analysis
Stock Information
Open
1.98
Close
1.88
High
1.99
Low
1.75
Previous Close
2.04
Daily Price Gain
-0.16
YTD High
182.00
YTD High Date
Apr 2, 2014
YTD Low
0.28
YTD Low Date
Mar 19, 2020
YTD Price Change
-79.37
YTD Gain
-97.69%
52 Week High
4.50
52 Week High Date
Mar 9, 2021
52 Week Low
1.38
52 Week Low Date
Apr 21, 2021
52 Week Price Change
-2.27
52 Week Gain
-54.70%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 15. 2017
6.76
Jul 6. 2017
8.47
14 Trading Days
25.29%
Link
LONG
Aug 21. 2017
9.75
Sep 20. 2017
16.48
21 Trading Days
69.07%
Link
LONG
Oct 16. 2017
36.53
Oct 19. 2017
39.39
3 Trading Days
7.83%
Link
LONG
Nov 9. 2017
37.57
Nov 10. 2017
39.59
1 Trading Days
5.36%
Link
LONG
Feb 20. 2018
19.37
Mar 7. 2018
23.09
11 Trading Days
19.20%
Link
LONG
May 7. 2018
23.27
Jun 5. 2018
43.05
20 Trading Days
84.99%
Link
LONG
Jun 22. 2018
62.14
Jun 28. 2018
65.59
4 Trading Days
5.54%
Link
LONG
Jul 11. 2018
56.16
Jul 30. 2018
67.28
13 Trading Days
19.79%
Link
LONG
Aug 21. 2018
60.97
Sep 7. 2018
72.57
12 Trading Days
19.02%
Link
LONG
Dec 30. 2020
0.62
Jan 27. 2021
2.81
18 Trading Days
355.80%
Link
LONG
Feb 5. 2021
3.56
Feb 18. 2021
4.72
8 Trading Days
32.69%
Link
Company Information
Stock Symbol
TRXC
Exchange
NYSE MKT
Company URL
http://www.transenterix.com
Company Phone
919-765-8400
CEO
Todd M. Pope
Headquarters
North Carolina
Business Address
635 DAVIS DRIVE, SUITE 300, MORRISVILLE, NC 27560
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Instruments & Supplies
CIK
0000876378
About

TransEnterix, Inc. operates as a development stage medical device company. It focuses on research, development and sale of medical device robotics to improve minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling n August 19, 1988 and is headquartered in Morrisville, NC.

Description

TransEnterix, Inc., a medical device company, focuses on the development and commercialization of surgical robotic systems. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port, robotically enhanced laparoscopic surgical platform. In addition, the company develops and manufactures flexible and rigid laparoscopic surgical instruments that are used in abdominal surgery, such as scissors, graspers, clip appliers, and suction and irrigation instruments. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading